Market Overview:
The global liver cancer diagnostics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of liver cancer, increasing awareness about early diagnosis and treatment of liver cancer, and technological advancements in diagnostic procedures. Based on type, the global liver cancer diagnostics market is segmented into biopsy, endoscopy, laboratory tests, imaging, and others. The biopsy segment is expected to account for the largest share of the global market in 2018. This can be attributed to the fact that biopsy is considered as a gold standard for diagnosis of various types of cancers including liver cancer. Based on application, the hospital segment accounted for the largest share of the global market in 2017.
Product Definition:
Liver cancer diagnostics is the process of detecting and diagnosing liver cancer. The importance of liver cancer diagnostics is that it allows for early detection and treatment of the disease, which can improve prognosis.
Biopsy:
A biopsy is a surgical procedure used to obtain tissue or fluid from a body part for examination under a microscope. Biopsies are most commonly used in the diagnosis of cancer, including liver cancer. Liver biopsies are taken to determine if there is any sign of malignant (cancer) liver disease at the time of initial screening and during follow-up visits for patients with chronic hepatitis C infection and alcoholic liver disease.
Endoscopy:
Endoscopy is a diagnostic procedure wherein the camera is inserted through the mouth and down the digestive tract to view and examine internal organs. In case of liver cancer, endoscopic ultrasound or biopsy may be recommended by doctors.
Application Insights:
Based on application, the market is segmented into hospital, clinic and laboratory. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as availability of advanced treatment facilities and a large number of patients suffering from chronic liver diseases or cirrhosis at a given time. Moreover, an increase in prevalence rates of hepatitis across the globe is further anticipated to boost demand for diagnostic solutions during the forecast period. For instance, according to WHO hepatocellular carcinoma (HCC) guidelines 2014; HCC accounts for approximately 10% - 15% cases globally while it ranges between 5% - 10% cases in most parts of Europe and North America. Thus increasing incidence rate coupled with high prevalence are expected drive demand for diagnostics over next few years which may eventually lead towards growth of this market by 2030 when compared with 2017 scenario.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and well-established healthcare infrastructure. Moreover, rising prevalence of liver cancer is expected to fuel regional growth over the forecast period. Asia Pacific is estimated to witness lucrative growth during the same period owing to improving healthcare facilities and increasing demand for oncological screening tests for patients from developing economies such as India and China. In addition, government initiatives are being undertaken in this region with an aim toward reducing disease burden by 2030%. Such initiatives include “Healthy Liver Month†held annually in October that aims at creating awareness about various diagnostic procedures used for liver diseases as well as their associated benefits among people throughout Japan.
Growth Factors:
- Increasing incidence of liver cancer
- Growing demand for early diagnosis and treatment of liver cancer
- Rising awareness about liver cancer and its symptoms
- Technological advancements in the field of diagnostics
- Availability of government funding for research on liver cancer
Scope Of The Report
Report Attributes
Report Details
Report Title
Liver Cancer Diagnostics Market Research Report
By Type
Biopsy, Endoscopy, Laboratory Tests, Imaging, Others
By Application
Hospital, Clinic, Laboratory
By Companies
Abbott Laboratories, BD, Roche Holding AG, Fujifilm Healthcare, Hologic, Illumina, Philips, Oncimmune, Qiagen, Siemens Healthineers, Sirtex Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
196
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Liver Cancer Diagnostics Market Report Segments:
The global Liver Cancer Diagnostics market is segmented on the basis of:
Types
Biopsy, Endoscopy, Laboratory Tests, Imaging, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Laboratory
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- BD
- Roche Holding AG
- Fujifilm Healthcare
- Hologic
- Illumina
- Philips
- Oncimmune
- Qiagen
- Siemens Healthineers
- Sirtex Medical
Highlights of The Liver Cancer Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Biopsy
- Endoscopy
- Laboratory Tests
- Imaging
- Others
- By Application:
- Hospital
- Clinic
- Laboratory
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Liver Cancer Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Liver cancer diagnostics is the process of detecting liver cancer in patients. This can be done through a variety of methods, including blood tests, imaging scans, and biopsies.
Some of the major players in the liver cancer diagnostics market are Abbott Laboratories, BD, Roche Holding AG, Fujifilm Healthcare, Hologic, Illumina, Philips, Oncimmune, Qiagen, Siemens Healthineers, Sirtex Medical.
The liver cancer diagnostics market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Liver Cancer Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Liver Cancer Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Liver Cancer Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Liver Cancer Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Liver Cancer Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Liver Cancer Diagnostics Market Size and Y-o-Y Growth
4.5.2 Liver Cancer Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Liver Cancer Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Liver Cancer Diagnostics Market Size Forecast by Type
5.2.1 Biopsy
5.2.2 Endoscopy
5.2.3 Laboratory Tests
5.2.4 Imaging
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Liver Cancer Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Liver Cancer Diagnostics Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Laboratory
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Liver Cancer Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Liver Cancer Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Liver Cancer Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Liver Cancer Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Liver Cancer Diagnostics Market Size Forecast by Type
9.6.1 Biopsy
9.6.2 Endoscopy
9.6.3 Laboratory Tests
9.6.4 Imaging
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Liver Cancer Diagnostics Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Laboratory
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Liver Cancer Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Liver Cancer Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Liver Cancer Diagnostics Market Size Forecast by Type
10.6.1 Biopsy
10.6.2 Endoscopy
10.6.3 Laboratory Tests
10.6.4 Imaging
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Liver Cancer Diagnostics Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Laboratory
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Liver Cancer Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Liver Cancer Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Liver Cancer Diagnostics Market Size Forecast by Type
11.6.1 Biopsy
11.6.2 Endoscopy
11.6.3 Laboratory Tests
11.6.4 Imaging
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Liver Cancer Diagnostics Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Laboratory
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Liver Cancer Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Liver Cancer Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Liver Cancer Diagnostics Market Size Forecast by Type
12.6.1 Biopsy
12.6.2 Endoscopy
12.6.3 Laboratory Tests
12.6.4 Imaging
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Liver Cancer Diagnostics Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Laboratory
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Liver Cancer Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Liver Cancer Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Liver Cancer Diagnostics Market Size Forecast by Type
13.6.1 Biopsy
13.6.2 Endoscopy
13.6.3 Laboratory Tests
13.6.4 Imaging
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Liver Cancer Diagnostics Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Laboratory
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Liver Cancer Diagnostics Market: Competitive Dashboard
14.2 Global Liver Cancer Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 BD
14.3.3 Roche Holding AG
14.3.4 Fujifilm Healthcare
14.3.5 Hologic
14.3.6 Illumina
14.3.7 Philips
14.3.8 Oncimmune
14.3.9 Qiagen
14.3.10 Siemens Healthineers
14.3.11 Sirtex Medical
